Don’t Be Fooled by Mycoplasma pneumoniae – It’s No Laughing Matter

Tuesday, April 1, 2025, 1:00 PM - 2:00 PM, Marlo Thomas Center Lecture Hall

Webex: Click Here

1. Evaluate the epidemiological trends of select respiratory illnesses in the post-COVID-19 era.
2. Review subtypes, clinical presentations, usually etiology, and antibiotic treatment.
3. Assess clinically relevant resistance patterns, including macrolide resistance for M. pneumoniae
4. Develop an evidence-based approach for management of M. pneumoniae, including regimens addressing the risk of potentially macrolide-resistant M. pneumoniae.

Webex : Click Here

Reminders for claiming CE

**Non-St. Jude employees will claim CE credit via a QR code provided during the presentation**

• Text attendance code during presentation (15 mins before/2 hours after)

• Login to your CloudCME profile and complete test and evaluation (ideally within 1 week of presentation)

• DO NOT USE ‘claim credit’ feature on CloudCME as this is not configured for pharmacy use

The St. Jude Children’s Research Hospital Department of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  

St. Jude Children’s Research Hospital designates this {Activity Format} for a maximum of {CME Hours} CPE hours (0.1 CEU per 1 CPE hour).

Pharmacy continuing education credit will be available to all participants who attend, text attendance, and complete a program assessment and evaluation. Credits will be uploaded and viewable on-line at www.napb.net within approximately two weeks following the date of the presentation.  Participants should contact the CPE staff if credit does not appear within 4 weeks of a program.

ACPE - Accreditation Council for Pharmacy Education (1.00 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.